{"id":"NCT00595309","sponsor":"Valneva Austria GmbH","briefTitle":"Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51","officialTitle":"Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51 on Long Term Immunogenicity. An Uncontrolled, Open-label Phase 3 Study.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-12","primaryCompletion":"2009-10","completion":"2009-10","firstPosted":"2008-01-16","resultsPosted":"2012-06-27","lastUpdate":"2014-05-16"},"enrollment":198,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Japanese Encephalitis"],"interventions":[{"type":"BIOLOGICAL","name":"IC51","otherNames":[]}],"arms":[{"label":"A","type":"ACTIVE_COMPARATOR"}],"summary":"The objective is to assess the effect of a booster vaccination on immunogenicity of IC51 in terms of seroconversion rate.","primaryOutcome":{"measure":"Seroconversion Rate","timeFrame":"at Month 12 after booster","effectByArm":[{"arm":"IC51 Booster Group","deltaMin":98.5,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":2,"exclusionCount":null},"locations":{"siteCount":3,"countries":["Austria","Germany"]},"refs":{"pmids":["21288804"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":8,"n":198},"commonTop":["Nasopharyngitis","Headache","Influenza Like Illnes","Fatigue","Myalgia"]}}